Glenmark’s Remogliflozin Hopes To Shake Up Indian SGLT2i Market

 
• By Anju Ghangurde
  
Diabetes
GLENMARK HAS LAUNCHED A NOVEL SGLT2 Inhibitor
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia